Lunit Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Lunit recognized for achievements in Screening & diagnostics

NEW YORK, August 13, 2020 -- CB Insights today named Lunit to its second annual  Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. 

The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others. 

Story image

“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year's class of the best in digital health."

“We are honored to be named as one of the most innovative digital health companies by CB Insights for two consecutive years,” said Lunit CEO Brandon Suh. “We are actively collaborating with global giants such as FujiFilm and GE Healthcare to provide our solution for precision diagnostics and therapeutics. Continuous recognition of our AI solution in Screening & diagnostics shall boost our footprint to set the new standard of healthcare.”

Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum. 

Lunit develops AI software to solve some of the most important problems today in cancer diagnosis and treatment. Lunit’s solution for imaging tests such as mammography and chest x-ray provide AI-powered detection of lesions that are suspicious of chest abnormalities and breast cancer with 96-99% accuracy. The software has received CE mark and has been featured in major publications including Radiology, Lancet Digital Health, JAMA Network Open, Clinical Infectious Diseases, and more. 

 

Quick facts on the 2020 Digital Health 150:

  • The 2020 Digital Health 150 startups have raised over $20B in funding across 600+ deals from 900+ unique investors.
  • The list includes 12 unicorns (companies that have reached a valuation of $1B+) focused on a diverse range of digital health solutions, including telehealth, insurance, and robotic surgical systems.
  • Many have formed partnerships with key industry players like the American Heart Association, Cigna, and Mount Sinai Health System. 

The Digital Health 150 Companies (in alphabetical order):

98Point6, Abacus Insights, AbCellera Biologics, Aetion, Akili Interactive Labs, Alan, Aledade, Alpha Health, Arterys, Atomwise, Avail Medsystems, Axial Healthcare, Babyscripts, Bend Financial, Bigfoot Biomedical, Bind Benefits, Biofourmis, Biointellisense, Bright Health, Bright.MD, BrightInsight, Brightside Benefit, Cala Health, Capsule, Caption Health, Carbon Health, Carrot Fertility, Cedar, Celsius Therapeutics, ChromaCode, Cityblock Health, CMR Surgical, Concerto HealthAI, Cricket Health, Cue Health, CureApp, Current Health, Dental Monitoring, Devoted Health, DispatchHealth, DNAnexus, Doctolib, Doctor On Demand, Dreem, Eko, Element Science, Evidation Health, Firefly Health, Folx Health, Freenome, Galileo Health, Genome Medical, GRAIL, GYANT, HaloDoc, Happify Health, Healthy.io, Healx, Heartbeat, Hims & Hers, Hinge Health, icometrix, iLoF, Incredible Health, Infervision, Innovaccer, Insilico Medicine, Insitro, Iora Health, K Health, Kaia Health, Karius, Kindbody, Komodo Health, League, LeanTaaS, LetsGetChecked, Livi, Lunit, Lyra Health, Mahmee, Mammoth Biosciences, Maven Clinic, Medable, Medbanks Network Technology, Medically Home Group, MediTrust Health, Meru Health, Mindbloom, Mindstrong, Modern Fertility, Mojo Vision, mPharma, nference, Notable, Nuvo Group, Olive, Omada Health, Oncology Analytics, Onera Health, Oscar Health, Oura, OWKIN, PAIGE.AI, Parsley Health, PathAI, Pear Therapeutics, Perspectum, PharmEasy, ProteinQure, Protenus, Quartet Health, Qure.ai, RDMD, Ready Responders, Recursion Pharmaceuticals, Redox, Ro, Saama Technologies, Science 37, Sema4, Somatus, SonarMD, SOPHiA Genetics, Subtle Medical, Taimei Technology, Tempus, Tencent Trusted Doctors, Thrive Earlier Detection, TriNetX, Truepill, Twistle, TytoCare, Unite Us, Unlearn, Valencell, Verana Health, Vesta Healthcare, Vicarious Surgical, VillageMD, Vim, Vineti, Virta Health, Viz.ai, We Doctor, Wellth, Winterlight Labs, Xealth, XtalPi, Zebra Medical Vision

About CB Insights

At CB Insights, we believe the most complex strategic business questions are best answered with facts.  We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.

About Lunit

With AI, Lunit aims to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide. We develop AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients. 
Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Our technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is headquartered in Seoul, South Korea with offices and representatives in the U.S.A., Netherlands, and China.

About Lunit

Perfecting Intelligence, Transforming Medicine.

With AI, we aim to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide.

We develop AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients.


Lunit, abbreviated from “learning unit,” is an AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit has been named by CB Insights as one of “AI 100” startups transforming healthcare industry.

Lunit's technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is based in Seoul, South Korea.

Lunit
15th floor, 27 Teheran-ro 2-gil, Gangnam-gu,
Seoul, South Korea